Dr. Robert Preti joins The Cell Culture Dish in advance of his upcoming keynote at CBI's Optimization of Cell and Gene Therapy Production Conference. The Cell Culture Dish states;
In this podcast and accompanying we interviewed Dr. Robert Preti about the past, present and future of global cell therapy manufacturing. We also discussed major industry milestones, manufacturing challenges and opportunities for the further improvements.
In the closing of the interview, Dr. Preti states "this is the most exciting time to be in this industry." Click below to listen to the podcast or click here to read more.
Join us at CBI's Optimization of Cell and Gene Therapy Production conference March 26-27 to hear from Dr. Robert Preti. Other PCT team experts, Brian Hampson and Dr. Courtney LeBlon, speak on the Development by Design methodology and best practices for closed processing and automation development. Please contact us if you have any questions.
*This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmbH are all now operating under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.